U.S. Nephrologists Report Mixed Reactions to the Approval of GSK's Jesduvroq® (daprodustat) for the Treatment of Anemia in Dialysis Patients, According to Spherix Global Insights

/PRNewswire/ -- Since 2017, Spherix Global Insights has been monitoring the U.S. renal anemia market landscape, capturing nephrologists' perceptions and...

Related Keywords

United States ,Astrazeneca Fibrogen Astellas ,Meghan Weiss ,Scott Upham ,Linkedin ,Twitter ,Corporate Communications ,Us Food Drug Administration ,Dynamix ,Spherix Network ,Spherix Global Insights ,Drug Administration ,Safety Information ,Black Box ,Realtime Dynamix ,Realworld Dynamix ,Complete Response Letters ,Launch Dynamix ,Time Dynamix ,World Dynamix ,Global Insights ,Global Insights Contacts ,Nephrology Insights ,Spherix Global Insight ,